One‐year clinical outcome with a novel self‐expanding transcatheter heart valve

OBJECTIVES: To evaluate 1‐year outcome using the ACURATE neo (Symetis S.A., a Boston Scientific Company, Ecublens, Switzerland) according to the updated Valve Academic Research Consortium (VARC‐2) with emphasis on the composite endpoints “clinical efficacy after 30 days” and “time‐related valve safe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Catheter Cardiovasc Interv
Main Authors: Pellegrini, Costanza, Rheude, Tobias, Trenkwalder, Teresa, Mayr, N. Patrick, Michel, Jonathan, Kastrati, Adnan, Schunkert, Heribert, Kasel, Albert M., Joner, Michael, Hengstenberg, Christian, Husser, Oliver
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2019
Teme:
VALVULAR AND STRUCTURAL HEART DISEASES
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899934/
https://ncbi.nlm.nih.gov/pubmed/30801906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccd.28144
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki